Autoimmune gastritis. Nat Rev Dis Primers, 2020;6(1): 57. https://www.nature.com/articles/s41572-020-0198-5.
Neumann WL, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–41.
Article CAS PubMed Google Scholar
Massironi S, et al. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215–22.
Shah SC, et al. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021;161(4):1325-1332.e7.
Article CAS PubMed Google Scholar
Taylor L, McCaddon A, Wolffenbuttel BHR. Creating a framework for treating Autoimmune Gastritis—The case for replacing lost acid. Nutrients. 2024;16(5):662.
Article CAS PubMed PubMed Central Google Scholar
Kulnigg-Dabsch S. Autoimmune gastritis. Wien Med Wochenschr. 2016;166(13–14):424–30.
Article PubMed PubMed Central Google Scholar
Osmola M, et al. Iron and vitamin B12 deficiency in patients with Autoimmune Gastritis and Helicobacter pylori Gastritis: results from a prospective multicenter study. Dig Dis. 2024;42(2):145–53.
Sato Y, et al. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol. 2016;22(30):6817–28.
Article CAS PubMed PubMed Central Google Scholar
Deng YF, Cui XS, Wang L. Reconceptualization of immune checkpoint inhibitor-associated gastritis. World J Gastroenterol. 2024;30(36):4031–5.
Article CAS PubMed PubMed Central Google Scholar
Harb AH, et al. Autoimmune gastritis treated with mycophenolate mofetil. ACG Case Rep J. 2020;7(12):e00496.
Article PubMed PubMed Central Google Scholar
D’Elios MM, et al. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med. 2004;10(7):316–23.
Article CAS PubMed Google Scholar
Lee GR. The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci. 2018;19(3):730.
Article PubMed PubMed Central Google Scholar
D’Elios MM, et al. H+, K+-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001;120(2):377–86.
Article CAS PubMed Google Scholar
Sebastián D, et al. TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging. Autophagy. 2024;20(8):1815–24.
Article PubMed PubMed Central Google Scholar
Della Bella C, et al. Gastric Th17 cells specific for H(+)/K(+)-ATPase and Serum IL-17 signature in Gastric Autoimmunity. Front Immunol. 2022;13:952674.
Article CAS PubMed PubMed Central Google Scholar
Garbers C, Lokau J. Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease. Expert Opin Ther Targets. 2024;28(1–2):57–65.
Article CAS PubMed Google Scholar
Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to Helicobacter pylori infection. Cell Microbiol. 2015;17(11):1570–82.
Article CAS PubMed Google Scholar
Bettelli E, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–8.
Article CAS PubMed Google Scholar
Kennedy CL, et al. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17. J Pathol. 2011;225(2):255–64.
Article CAS PubMed Google Scholar
Balic JJ, et al. Constitutive STAT3 serine phosphorylation promotes helicobacter-mediated gastric disease. Am J Pathol. 2020;190(6):1256–70.
Article CAS PubMed Google Scholar
Hoft SG, et al. Unveiling cancer-related metaplastic cells in both Helicobacter pylori Infection and Autoimmune Gastritis. Gastroenterology. 2025;168(1):53–67.
Article CAS PubMed Google Scholar
Liu M, et al. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2022;13(3):287.
Article CAS PubMed PubMed Central Google Scholar
Huang B, Lang X, Li X. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177.
Article CAS PubMed PubMed Central Google Scholar
Hillmer EJ, et al. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016;31:1–15.
Article PubMed PubMed Central Google Scholar
Ashrafizadeh M, et al. STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology (Basel). 2020;9(6):126.
Ouyang S, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317.
Article CAS PubMed PubMed Central Google Scholar
Joo M, et al. GDF15 promotes cell growth, migration, and invasion in gastric cancer by inducing STAT3 activation. Int J Mol Sci. 2023;24(3):2925.
Article CAS PubMed PubMed Central Google Scholar
Jin D, et al. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota. Gut Microbes. 2022;14(1):2120744.
Article PubMed PubMed Central Google Scholar
Inagaki-Ohara K, et al. Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice. Nutr Metab (Lond). 2016;13:7.
Kamada T, et al. Endoscopic features and clinical importance of autoimmune gastritis. Dig Endosc. 2022;34(4):700–13.
Rusak E, et al. Anti-parietal cell antibodies - diagnostic significance. Adv Med Sci. 2016;61(2):175–9.
Qu Y, et al. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. Int J Cancer. 2022;150(8):1373–91.
Article CAS PubMed Google Scholar
Kumar R, Theiss AL, Venuprasad K. RORγt protein modifications and IL-17-mediated inflammation. Trends Immunol. 2021;42(11):1037–50.
Comments (0)